Compare Humana Inc (HUM) vs JPMorgan Equity Premium Income ETF (JEPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs JPMorgan Equity Premium Income ETF — how do they compare? Humana Inc trades at $445 (market cap $47.61B), while JPMorgan Equity Premium Income ETF trades at $56.67 (market cap $45.47B). The key difference: Humana Inc and JPMorgan Equity Premium Income ETF are close in size by market cap, and Humana Inc pays a 0.89% dividend while JPMorgan Equity Premium Income ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and JPMorgan Equity Premium Income ETF for 56 Days on average.
| HUM | JEPI | |
|---|---|---|
Market Cap | $47.61B | $45.47B |
Volume | 1,827,332 | 4,270,613 |
Sector | Health | Income / Options Overlay |
52-Week High | $409.85 | $59.88 |
52-Week Low | $163.67 | $55.29 |
Typical Hold Time | 53 Days | 56 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
JEPI trades at $56.45, down 0.16% with a bearish technical outlook. The ETF shows neutral momentum oscillators but bearish moving averages, with key support at $56 and resistance at $57. Recent dividend payments of $0.34-$0.37 highlight its income-focused strategy, though financial ratios remain undisclosed in current data.
JEPI's covered-call strategy provides monthly income but faces headwinds from Fed rate hikes and tax implications. Media sentiment is mixed, emphasizing income benefits versus growth trade-offs. Analyst coverage suggests cautious optimism given institutional inflows, though market volatility and income strategy limitations pose risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About JPMorgan Equity Premium Income ETF
JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →
